Inovio Pharmaceuticals
INO
#9678
Rank
NZ$0.15 B
Marketcap
NZ$1.94
Share price
-1.79%
Change (1 day)
-42.04%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): NZ-$4.80

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$5.07. In 2024 the company made an earnings per share (EPS) of NZ-$6.96 an increase over its 2023 EPS that were of NZ-$10.73.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.80-30.96%
2024NZ-$6.96-35.14%
2023NZ-$10.73-56.62%
2022NZ-$24.74-19.54%
2021NZ-$30.7435.9%
2020NZ-$22.62-11.57%
2019NZ-$25.5815.24%
2018NZ-$22.20-2.78%
2017NZ-$22.836.93%
2016NZ-$21.35134.88%
2015NZ-$9.09-29.51%
2014NZ-$12.90-57.34%
2013NZ-$30.23146.55%
2012NZ-$12.2620.83%
2011NZ-$10.15-29.41%
2010NZ-$14.38-48.48%
2009NZ-$27.9110%
2008NZ-$25.3711.11%
2007NZ-$22.83-41.3%
2006NZ-$38.90-66.91%
2005NZ-$117.55110.61%
2004NZ-$55.81-61.63%
2003NZ-$145.45186.67%
2002NZ-$50.74
2001N/A-100%
2000NZ-$40.59-63.64%
1999NZ-$111.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.39-403.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.37-343.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.31-145.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$12.07-337.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.27-223.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.85-234.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
NZ$0.62-112.15%๐Ÿ‡บ๐Ÿ‡ธ USA